Impact of Elagolix on Health-Related Quality of Life Among Patients with Moderate to Severe Endometriosis-Associated Pain: Analysis of EQ-5D-5L Data from a Phase III Randomized Controlled Trial

SK Agarwal, AM Soliman, Brittany Schwefel, Paul M. Peloso, ES Surrey, H.S. Taylor
In: Value in Health · 2018 · vol. 21 , pp. S144–S145 · doi:10.1016/j.jval.2018.04.1014 · W2810615203
article OA: bronze CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study analyzed EQ-5D-5L data from a Phase III trial to assess the impact of elagolix on health-related quality of life in patients with moderate to severe endometriosis-associated pain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK